Healthcare CMO Market, By Service (Pharmaceutical Contract Manufacturing Services, Medical Device Contract Manufacturing Services), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, Africa) - Size, Share, Outlook, and Opportunity

Healthcare CMO Market, By Service (Pharmaceutical Contract Manufacturing Services, Medical Device Contract Manufacturing Services), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

A contract manufacturing organization, also known as a contract manufacturing and development organization, is an organization that serves pharmaceutical companies on a contract basis to offer comprehensive services from invention through commercialization to provide pharmaceuticals for healthcare. The primary function of these organizations is to provide the pharmaceutical and biotechnology industries with products that are designed, developed and manufactured under contract. Contract manufacturers usually build their business in close association with the pharmaceutical and bio-tech groups. As a result of this close relationship, these organizations can offer the same quality and quantity of products that would be available through the licensed facility. There are a number of advantages to contract manufacturing from a contract manufacturer.
Market Dynamics:
Increasing investment in R&D of drugs is expected to propel growth of the global healthcare CMO market over the forecast period. For instance, in September 2021, Aragen Life Sciences announced its plans to invest in expanding infrastructure in Hyderabad and Bengaluru (India) for drug discovery, and building a new facility in the U.S to manufacture biologics. Similarly, in August 2021, Curia announced plans to expand its commercial manufacturing capacity at its Rensselaer, NY facility.
Key features of the study:
This report provides in-depth analysis of the global healthcare CMO market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global healthcare CMO market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Accellent, Inc., Boehringer Ingelheim GmbH, Catalent Pharma Solutions, Inc., DSM, Fareva, Greatbatch, Inc., Lonza Group, Patheon, Inc. (Thermo Fisher Scientific Inc.), Piramal Healthcare, Binex, Cytovance Biologics, Emergent BioSolutions Inc., MilliporeSigma, Symbiosis Pharmaceutical Services, Albany Molecular Research Inc., Samsung Biologics, and Symmetry Medical, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global healthcare CMO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global healthcare CMO market
Detailed Segmentation:

Global Healthcare CMO Market , By Service:
Pharmaceutical Contract Manufacturing Services
Medical Device Contract Manufacturing Services
Global Healthcare CMO Market, By Region:
North America
North America Healthcare CMO Market , By Service:
Pharmaceutical Contract Manufacturing Services
Medical Device Contract Manufacturing Services
By Country
U.S.
Canada
Latin America
Latin America Healthcare CMO Market , By Service:
Pharmaceutical Contract Manufacturing Services
Medical Device Contract Manufacturing Services
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Europe Healthcare CMO Market , By Service:
Pharmaceutical Contract Manufacturing Services
Medical Device Contract Manufacturing Services
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Asia Pacific Healthcare CMO Market , By Service:
Pharmaceutical Contract Manufacturing Services
Medical Device Contract Manufacturing Services
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Middle East Healthcare CMO Market , By Service:
Pharmaceutical Contract Manufacturing Services
Medical Device Contract Manufacturing Services
By Country
GCC
Israel
Rest of Middle East
Africa
Africa Healthcare CMO Market , By Service:
Pharmaceutical Contract Manufacturing Services
Medical Device Contract Manufacturing Services
By Country
North Africa
Central Africa
South Africa
Company Profiles
Accellent, Inc.*
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategy
Boehringer Ingelheim GmbH
Catalent Pharma Solutions, Inc.
DSM
Fareva
Greatbatch, Inc.
Lonza Group
Patheon, Inc. (Thermo Fisher Scientific Inc.)
Piramal Healthcare
Binex
Cytovance Biologics
Emergent BioSolutions Inc.
MilliporeSigma
Symbiosis Pharmaceutical Services
Albany Molecular Research Inc.
Samsung Biologics

“*” marked represents similar segmentation in other categories in the respective section.